Think Discovery

How do you turn your research into therapies? Discovery starts with a strategic approach with your path to clinic in mind. We’ll collaborate through a combination of integrated, multidisciplinary drug discovery expertise and capabilities in targets, platforms, and therapeutic areas, across modalities. Your drug discovery program will progress with the trusted data and insights from our team of experts.

With >100 pre-clinical candidates delivered, >490 patents granted, and >270 peer reviewed co-authored publications, our unique combination of integrated, multidisciplinary drug discovery expertise and unparalleled scope of capabilities in targets, platforms, and therapeutic areas allow us to deliver depth and breadth in science with data and insight you can trust.

Integrated Drug Discovery

Time to clinic can be reduced by one year with an integrated drug discovery approach, whereby target discovery, hit id, hit-to-lead, lead optimization, safety, and toxicology is managed by the same project team.

Logica™ - Transformative Drug Discovery  

Charles River and Valo Health are transforming drug discovery with Logica, a customized turnkey small molecule discovery solution from target to preclinical development.

Antibody Discovery Services

Rapid solutions to generate truly unique and clinically relevant antibody candidates. Explore our options for lead discovery, upstream antibody safety and efficacy, and in vivo studies, all to designed to expedite your path to the clinic.

Pharmacology Studies

In vitro to in vivo translation is difficult, costly, and often fails. Advance your discovery research with our translationally focused approach across a range of therapeutic areas including Oncology, Neuroscience, and Immunology.

Screening and Profiling Assays

From target validation to lead identification and optimization, the right combination of biochemical and cell-based assays progresses translational success.

Chemistry

Discovery chemists guide key decisions by considering factors such as client intellectual property (IP) generation, compound stability for in vivo studies, solubility and other poor property issues, weak exposure in an animal, and off-target selectivity.

DMPK/ADME

Leverage our comprehensive laboratory services such as DMPK/ADME, bioanalytical services, biomarker testing, immunology testing, formulation development, and clinical laboratory support.